These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 9851436

  • 1. Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study.
    Buchwald B, Toyka KV, Zielasek J, Weishaupt A, Schweiger S, Dudel J.
    Ann Neurol; 1998 Dec; 44(6):913-22. PubMed ID: 9851436
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Combined pre- and postsynaptic action of IgG antibodies in Miller Fisher syndrome.
    Buchwald B, Bufler J, Carpo M, Heidenreich F, Pitz R, Dudel J, Nobile-Orazio E, Toyka KV.
    Neurology; 2001 Jan 09; 56(1):67-74. PubMed ID: 11148238
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding.
    Jacobs BC, O'Hanlon GM, Bullens RW, Veitch J, Plomp JJ, Willison HJ.
    Brain; 2003 Oct 09; 126(Pt 10):2220-34. PubMed ID: 12876146
    [Abstract] [Full Text] [Related]

  • 9. Presynaptic effects of immunoglobulin G from patients with Lambert-Eaton myasthenic syndrome: their neutralization by intravenous immunoglobulins.
    Buchwald B, Ahangari R, Weishaupt A, Toyka KV.
    Muscle Nerve; 2005 Apr 09; 31(4):487-94. PubMed ID: 15685615
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Ca channel currents inhibited by serum from select patients with Guillain-Barré syndrome.
    Nakatani Y, Kawakami K, Nagaoka T, Utsunomiya I, Tanaka K, Yoshino H, Miyatake T, Hoshi K, Taguchi K.
    Eur Neurol; 2007 Apr 09; 57(1):11-8. PubMed ID: 17108689
    [Abstract] [Full Text] [Related]

  • 16. Anti-GM1 IgG antibodies induce leukocyte effector functions via Fcgamma receptors.
    van Sorge NM, van den Berg LH, Geleijns K, van Strijp JA, Jacobs BC, van Doorn PA, Wokke JH, van de Winkel JG, Leusen JH, van der Pol WL.
    Ann Neurol; 2003 May 09; 53(5):570-9. PubMed ID: 12730990
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. N-glycolylneuraminic acid-containing GM1 is a new molecule for serum antibody in Guillain-Barré syndrome.
    Odaka M, Yuki N, Yoshino H, Kasama T, Handa S, Irie F, Hirabayashi Y, Suzuki A, Hirata K.
    Ann Neurol; 1998 Jun 09; 43(6):829-34. PubMed ID: 9629854
    [Abstract] [Full Text] [Related]

  • 19. Demyelination in vivo by Guillain-Barré syndrome and other human serum.
    Brown MJ, Rosen JL, Lisak RP.
    Muscle Nerve; 1987 Jun 09; 10(3):263-71. PubMed ID: 3561445
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.